The PharmaEssentia Innovation Research Center (PIRC) will advance the company’s diverse pipeline and research footprint in the U.S., driving job creation
If approved, the vaccine could help simplify the meningococcal vaccination schedule and provide the broadest serogroup coverage of any meningococcal vaccine
35 million mosquito nets supplied to countries in sub-Saharan Africa through partners
Antibody levels remained above baseline six months after completion of a three-dose (Month 0-2-6) or a two-dose (Month 0-6) vaccination schedule
It allows users to generate cell lines suitable for clinical development without their own starter cells, vectors or prior experience in the field.
Pfizer plans to submit an sBLA by the end of this year, subject to discussions with U.S. FDA
Capnomed successfully introduced the medical device Capnopen, the gold standard of laparoscopic nebulizers.
CEPI will provide seed funding of up to US$2.5 million to Codiak BioSciences.
Vaccizone’s ASC Technology is an enhanced antigen/bioactive delivery method based on Antigen Presenting Cells
Dupixent is the first and only biologic medicine approved to treat moderate-to-severe atopic dermatitis from infancy to adulthood
Subscribe To Our Newsletter & Stay Updated
